Ergomed (ERGO)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

Trade now with BarclaysStockbrokers Trade now with Barclays Sponsored by Barclays Stockbrokers

 323.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 325.00
  • 52 Week Low: 147.50
  • Currency: UK Pounds
  • Shares Issued: 46.97m
  • Volume: 5,368
  • Market Cap: 151.70m
  • Beta: 0.00

Financial Analysis

Select chart: EPS | Dividend | Revenue

Key Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-14 21.16 0.78 2.40p 63.5 n/a n/a n/a 0.0%
31-Dec-15 30.18 2.07 9.50p 17.8 0.1 +296% n/a 0.0%
31-Dec-16 39.23 (0.22) 6.80p 22.4 n/a -28% n/a 0.0%
31-Dec-17 47.62 (4.45) 4.20p 43.7 n/a -38% n/a 0.0%
31-Dec-18 54.11 (10.77) 1.90p 82.6 n/a -55% n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-19 66.17 6.69 12.43p 26.0 0.0 +554% n/a 0.0%
31-Dec-20 74.98 8.46 15.18p 21.3 1.0 +22% n/a 0.0%

Copyright © 2019 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest 82.63 17.84 46.03 3.69

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

Ergomed Market Data

Currency UK Pounds
Share Price 323.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 325.00
52 Week Low 147.50
Volume 5,368
Shares Issued 46.97m
Market Cap 151.70m
Beta 0.00

Ergomed Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
39.63% below the market average39.63% below the market average39.63% below the market average39.63% below the market average39.63% below the market average
28.81% above the sector average28.81% above the sector average28.81% above the sector average28.81% above the sector average28.81% above the sector average
Price Trend
97.81% above the market average97.81% above the market average97.81% above the market average97.81% above the market average97.81% above the market average
90.00% above the sector average90.00% above the sector average90.00% above the sector average90.00% above the sector average90.00% above the sector average
Income Not Available
Growth
42.33% below the market average42.33% below the market average42.33% below the market average42.33% below the market average42.33% below the market average
89.47% below the sector average89.47% below the sector average89.47% below the sector average89.47% below the sector average89.47% below the sector average

What The Brokers Say

Strong Buy 2
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 2
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Ergomed Dividends

No dividends found

Trades for 21-Aug-2019

Time Volume / Share Price
16:35 5,000 @ 322.50p
11:45 89 @ 322.50p
08:15 279 @ 320.50p

Ergomed Key Personnel

COO Jan Petracek

Top of Page